Morgan Stanley
ASTX

Morgan Stanley’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Morgan Stanley’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,023,273
Closed -$8.69M – 6456
2013
Q3 		$8.69M Buy
1,023,273
+228,912
+29% +$1.45M ﹤0.01% 1896
2013
Q2 		$3.27M Buy
+794,361
New +$4.27M ﹤0.01% 2726

Morgan Stanley's ASTX Position: Q4 2013 in Review

Morgan Stanley sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 1,023,273 shares — an estimated $8.69M sold.

Morgan Stanley first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $8.69M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Morgan Stanley reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Morgan Stanley sold 1,023,273 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $8.69M.
  • Morgan Stanley first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Morgan Stanley's ASTEX PHARMACEUTICALS, INC COM position peaked at $8.69M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Morgan Stanley's 13F filing for Q4 2013, filed 13 Feb 2014.